Document reference

2021/2718(DEA)  
Criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans  
Basic information  

2021/2718(DEA)

DEA - Delegated acts procedure

Supplementing 2014/0257(COD)

Subject
3.10.08 Animal health requirements, veterinary legislation and pharmacy
4.20 Public health
4.60.04.04 Food safety

Status

Procedure completed - delegated act enters into force

 

Please go to Documentation gateway for any follow-up documents.: Please go to Documentation gateway for any follow-up documents. 
Key players  
Key events  
10/03/2016
Matter referred back to the committee responsible
26/05/2021
Non-legislative basic document published
C(2021)03552
26/05/2021
Initial period for examining delegated act 2 month(s)
09/06/2021
Committee referral announced in Parliament
14/07/2021
Initial period for examining delegated act extended at Parliament's request by 2 month(s)
15/09/2021
Decision by Parliament
14/10/2021
Delegated act not objected by Parliament
Technical information  
Procedure reference
2021/2718(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Legal basis
Rules of Procedure EP 114-p03
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/9/06142
Documentation gateway  
  • European Parliament 
    Motion for a resolution objecting delegated act
       
    B9-0424/2021  
    08/09/2021
    EP
     
  • European Commission 
    Non-legislative basic document
     
    C(2021)03552  
    26/05/2021
    EC
     
  • All 
    Non-legislative basic document
       
    C(2021)03552  
    26/05/2021
    EC
     
    Motion for a resolution objecting delegated act
       
    B9-0424/2021  
    08/09/2021
    EP